Male Cancer Market: Brief Account
The robust growth in the healthcare
sector has provided respite from cancer all across the world. It has
been able to provide a wide margin of life expectancy to the cancer
patients. According to World Health organization, near 8.2 mn
individuals died due to cancer in 2012. It is estimated that near around
14% of annual death is caused by various types of cancers. Though the
healthcare sector is extensively finding ways to treat but on the other
hand newer cases of cancers are emerging every year. Various reasons are
found for causing cancers but there are still cases which are shock to
the healthcare sector. Major reason fueling the male cancer market is
the change in lifestyle. It has been noticed that colorectal cancer,
lymphoma, lung cancer, and carcinoma are presented at a significant
figure by males.
The global male cancer market can be
classified on the basis of end users, regions, and product type. On the
basis of end users the market is classified into clinics, hospitals, and
others. Amongst these, hospitals accounted for the most number of
footprints owing to the presence of better devices, treatment, test
equipment and better facilities.
Analysts of the report have provided a
complete 360 degree overview of the market thus helping the readers to
get a better insight of the market. Analysts have collected information
from primary and secondary research source. In order to get a better
analysis of the market, analysts have taken help from Porter’s Five
Force analysis. The report consists of various market dynamics such as
trends, opportunities and restraints which might have a tremendous
impact on the growth of the market. Report also provides company
profiles of the major players in the market.
Male Cancer Market: Trends and Opportunities
Male cancer market is majorly driven by
unhealthy diet, exposure to carcinogenic elements, and hereditary
factors. It has been figured out that male specific cancer consists of
testicular cancer, penile cancer, and prostate cancer. According to WHO,
the major occurring case of cancer in males is prostate cancer. It has
been found that the male specific cancers are normally malignant/benign
tumors that hardly undergoes metastasis. Most of these kind of diseases
in males are due to the metastasis of caners that leads to complete or
peripheral damage of the organs. Genetic factors are considered to be
the major reason behind the spread of cancer, particularly in males
above 45 years old.
Prostate cancer are mostly slow in
nature, however in some cases aggressive prostate cancer has been found
which spread at a good pace, damaging other organs. North America holds
the top position in prostate cancer whereas Asia Pacific holds the
bottom position. However the growing trend of prostate cancer can be
attributed to the rise in geriatric population, change in lifestyle
factors such as consumption of red meat and smoking. According to
studies it has been found that recently that nearly more than half the
male population smoke every day in various countries such as Russia,
Armenia, Indonesia, and Timor Leste. High rise of smoking in teens is
also an important factor which later leads to prostate or lung cancer.
It has been found that nearly 90% of adult start smoking before the age
18. However, several initiative undertaken by government of various
countries to prevent cigarettes is helping to reduce the consumption of
cigarette on daily basis. Spreading awareness by non-governmental and
governmental bodies to understand the symptoms of cancer in first hand
is helping to provide treatment in early months.
Male Cancer Market: Geographical Analysis
On the basis of geography, the market is
spread across North America, Europe, Middle East and Africa, and Asia
Pacific. Amongst the pack, North America dominates the pack owing to the
well-developed healthcare sector, excellent insurance penetration, and
high healthcare expenditure. Europe holds the second position, with
Germany contributing the most.
Male Cancer Market: Companies Mentioned
Some of the major players in the market
are Taokai Pharmaceuitcal, Inc., Progentics Pharmaceuticals, Inc.,
TOLMAR Inc., and OncBioMune Pharmaceuticals Inc.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment